These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10750261)

  • 1. Safe and effective management of hypertension with fixed-dose combination therapy: focus on losartan plus hydrochlorothiazide.
    Benedict CR
    Int J Clin Pract; 2000; 54(1):48-54. PubMed ID: 10750261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
    Abe M; Okada K; Matsumoto K
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive efficacy and safety of fixed-dose combination therapy with losartan plus hydrochlorothiazide in Japanese patients with essential hypertension.
    Saruta T; Ogihara T; Matsuoka H; Suzuki H; Toki M; Hirayama Y; Nonaka K; Takahashi K
    Hypertens Res; 2007 Aug; 30(8):729-39. PubMed ID: 17917321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
    Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
    Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Matsumoto K
    Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fixed-combination of losartan/hydrochlorothiazide 100 mg/25 mg. Tolerability and efficacy on blood pressure measured in the practice and for 24 hours].
    Förster A; Smolka W; Jung C; Bestehorn K
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():111-8. PubMed ID: 17955788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
    Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
    J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y; Liu G; Jiang B; Gao R; Chen L; Su L; Li J
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of strict blood pressure lowering by losartan/hydrochlorothiazide combination therapy and high-dose amlodipine monotherapy on microalbuminuria: the ALPHABET study.
    Fukutomi M; Hoshide S; Eguchi K; Watanabe T; Shimada K; Kario K
    J Am Soc Hypertens; 2012; 6(1):73-82. PubMed ID: 22054782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
    Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y;
    J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
    Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive efficacy of monotherapy in increasing doses versus therapy associated in low doses].
    Fasce E; Wagemann H
    Rev Med Chil; 1999 Aug; 127(8):911-8. PubMed ID: 10752251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of losartan and losartan/hydrochlorothiazide fixed-combination on magnesium, zinc, and nitric oxide metabolism in hypertensive patients: a prospective open-label study.
    Koren-Michowitz M; Dishy V; Zaidenstein R; Yona O; Berman S; Weissgarten J; Golik A
    Am J Hypertens; 2005 Mar; 18(3):358-63. PubMed ID: 15797654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.